reading matter, including "anti-ETS" articles. The\ are asked for a genuine opinion as independent consultants, and if thev indicate an interest in pro- ceeding further a Philip Morris scientist makes contact. Philip Morris then expects the group of scientists to operate ivithin the confines of dcci- sions taken by PM scientists to determine the gen- eral direction of research, r\,hich apparentI\. \I-ould then be "filtered" L7y la\vyers to eliminate areas of sensitivity (p. 3). As this obserlw notes. "Although the industr\. is in great need of concerted effort and action in the, questionable" (Boyse lYW,`p. 27-l. Chapman (IWT) has described this 198X memo as one that "pr~~mi5e.s to blo\v apart the facade that the tobacco industr\ carries out neutral research into passi1.e sniokins" (p. I S6Y). A study published in Ma\- IYYK in tht> /~~1/~.~~111 cli t//c ArrwriiIT,! -Mdiid .-\~sclillllj~ll,-(Bdl.nt"; and Bern 1 `NX) concluded that of the 31 percent (3`) out of 106j oi ar- ticles re\.ie\ved that concluded that ETS is not harmful tn health, 7-l percent (2Y out of 39) of these \\ere \\.ritten by authors ivith tobacco industrv affiliations. In this surve!; the authors included articles \vhose stated or implied purpose \zas to re\-ie\\- the scientific cx.idencc that ET5 is associated mith one or more health outcomes. rirticles were excluded if thev did not focus specificnll!~ on the health effects of ETS or if thev \sere not \vritten in English. The authors noted, "In Inultiple logistic rc- gression analvses controlling for article qualit!; ptw revierv status,-article topic, and year of publication, the 0nlv factor associated ivith concluding that paisi1.c smoking is not harmful leas Lvhether an author \j'as affiliated \vith the tobacco industrv" (p. 1566). The au- thors also found that the "conclusi& of re\.ie\v articles are stronglv associated with the affiliations of their ELI- thors. Authors of re\ie\v articles should disclose pu- tcntial financial conflicts of interest, and readers should consider authors' affiliations i\,hen deciding ho\z. to iudge an article's conclusions" (p. 1366). Other Idusty-Syorrsored Oyyositiolr to Stntc Tobacco Control lllitiativrs lzmi Advocates Tobacco interests have used the courts proactively against other measures to prel'ent smok- iilg. The proliferation of third-rvnve litigation against the tobacco industry has been matched by a more ag- :$essive use of litigation bv tobacco interests. For VY- alnjple, the industry and iis allies filed a prccmpti\-t` ~lldllenge, on state constitutional gro~~iids, 10 the Arguably,, the most s\veeping litigation measure taken by, the tobacco industry ~vas initiated on August IO, lYY?, \vhen Philip Morris and others filed suit to block the FDA from regulating the sale, promotion, and distribution of cigarettes to minors. Discussed earlier in this chapter (see "Further Regulatory Steps"), the suit challenged the agenc\r's authorit\ to regulate ciga- rettes under the Federal Food, Drug, and Cosmetic Act. The la\rsuit further charged that the proposed regula- tions \vould violate the tobacco companies' freedom of speech and xvould impair their ability to compete (Collins lYY5b). Tobacco companies ha\,e also used litigation tac- ticdllv to iimpede the flon- of darnaging information. Bro\v~n & Willianxon Tobacco Corporation brought suit against a paralegal aide accused of stealing confiden- tial and potcntiall~~ incriminating documents ilVj/flft, Torrilrlf & COIII~S 7'. h'ilh7777s, 8Y2S.W.2d 5X4 [Kv. lY%]). The documents, scxme of xhich w'ere ultimately ob- taintvl Lx. members of Congress, ha\ t` sho1z.n that the tob,\ic~~-m,,nui,lc~tu~-t'r~ not c~nlv knc\v of both the addiiti\,tx and the ial-cino;gtwic prc~yerties i>f tptmding on the outcome of a litigation, similarly situ~ilted injurd parties, for example, may abandon or mcdih-or con\-ersely, inay decide to continue-their ri5h-cl'edting beha\.ior or may be either encouraged to make ~~ Iq+il claim or discouraged from claiming. Law- I crs ma\ be encouraged to mount or discouraged from &ountii;;: claims or defenses. Unin\,olved actors (such ds pi>tcn&l business partners) 1~1~0 anticipate dealing 11 ith parties or potential parties may respond to liti- CT ition signals b\, mdif\ing (or e\`en terminating) their h` dc,ilin;ls \\.ith those parties. Such signals may be de- r-i\ cd not onI\- from ,iuthoritati\.c decisions but also frc>m the pro&s of the litigation itself, Lvhich may ex- hibit ad\.antages to be gained or costs to be a\,oided. For example, iie\\`s organizations \.ielving the fierce and e\pcvisi\.e industr\f response to critical depiction ni;1\. hesitate to yortrav industrv practices negatively (Fr&dtmnn and Ste\.e& 1995). . Xlore often, third-,,,d,.e tobacco litigation pro- \-ides dramatic e\.idence of the indirect, dnticipatory effects of litigation on reducing tobacco use. In early 1995, three pron-tinent manufacturers recoiled from business dealings \vith cigarette makers to avoid the rish of getting embroiled in liability litigation. The .M~in\~illc Corporation sued R.J. R&nolds Tobacco Company for a declaratory judgment that the corpo- ration does not have a contract to supply fiberglass for cigarette filters (Appleson 1995). A fexv days later, Harlev-Davidson, Inc., responding to a 1993 suit by the Lorillard Tobacco Company to enforce an agree- ment licensing the rnoforcyclc maker's name for a brand of cigarettes, countersued, alleging that tobacco liability risks reduced Lorillard's ability to fulfill its contract (Rose and Hlvang 1995). Papermaker Kimberly-Clark Corporation (which had been named a dct'endant in the West Virginia health care provider suit), the x4,orld leader in tobacco papers, decided to sell its cigarette paper business. The company denied that liability fears or shareholder acti\%m played any part in its decision, but anal>`sts said that such con- cerns tvere dominant factors (Collins 199_?a). Other companies, such ds Pfizer, ha\,e dopted policies "pro- hibiting units from doing business tlrith Big Tobacco dnd its suppliws" (Mallory lc)93, p. 39). .~llL3tllty set ot ,liti~rs rt5ponsi\ c` to 5ignal5 about liability arc in3urer5. I'rt5ulllabl~~, \ irtuall!, ,111 of the suppliers and professionals \\-hco ser\`e cigarette mak- Cl-S Ccll-n` liaI?ilit!* insurance. Pht? tOhCC0 lll~1lllfZlCtLl~- crs themsel\.es ha\-e been insured for at least some liability risle, altllougll the iilllOullt 0t' insurance co\`- erase of the tobacco companies is unkno\z.n (Reidv and Carter lYY5). lf an!; of these insured parties are found liable for promoting or sellin, 0 tobacco products, the il7t;Llrers ccjil be e\pt~cted to contest Cot erase, using aS defensty against liability to the insured llldllv of the same arguments that plaintiffs use to establish the li- ability of the insured. If, tor example, liability involves attribution to the industry (It I\llLliVldgc Of a CZlLlSill link to disease or concealment of that information, then to defeat col'erage, the insurer ma\' likelvise claim that the insured had \\~ron#ullj~ and kilo\\-insly obtained co\-el-agf fL)r J business practice lvhose dangers xvere concealed from the insurer. "In effect," note tivo ana- Ivsts, "the insurance industrv L\.ill ha1.e to pro1.e the \`erv thing the polic\.holder -is trying to deny in tile tobacco-related suits" (Reid,, andCarter 1995, p. S38). Thus a "breakthrough" bv tobacco plaintiffs may lead to a "second front" of liability battles bet\Veen tobaCC0 defendants and their insurers. Indeed, in lC)Yh. Imperial Tobacco Limited (No. j00-05-01~08~-Yh~ [Canada S. Ct., Pro\. of Quebec, Dist. of Montreal Jan. 12, IYYhl, c-lfc'ti irk 11. 1 Tl'Lli 3.3`1 [ IYY~]) filed suit in the Superior Court of Queb~i a g a i ii s t t iv 0 To r 0 ii t 0 - I2 a 5 e d I i d b i 1 i t \' i n 5 u r rl n 5 t' comy~l~~ies-A~~~erii;ln Home Insuranic Cr)mpan\, and Commercial Union Assurance Cornpan\, of Cai7ada-demandi~~~ that the!. pa>' legal CO~tS~dllcI any damages arisin;; from a clays action suit filed against Imperial in Ontario b\. \,tr. Da\-id CapLIt<) and three other persons in IYYj. The Canadian class I1c- tion suit, \\,hich has not Fct beell resol\-ed, See!+ ~ldlll- ages on behalf of nicotine-acidicted persons \t.hr-, ll~l\Y suffered because of their addiction to nicotine. lrnpe- ria[ claims to ha\.e hacl policies issued b\, the insurers obligating them to reimburse Imperial for ICgdl i,)StS incurred in the class action and to pa\' dll\' turther cost4 thev may incur in this matter. The tobacco compan!. is, in essence, asking the Superior CoLlrt of QLIebec ford declaration that the ti\-o named insurance companies must pav all of Imperial's It,` )`711 ices and all SLlI-llS a,-ardeJ b\i an e\.entual finding of liability b\, the Olltario co& c fih~ccc~ f'r~~f~rcf~ Lifr;, 011 the jLttLil-e profitability and sol\,enc\. of the tobacco COIlI- patlies. T&~,lcco cases are close]\, tracked bi, ini.est- ment an,il\,sts, and "t'\.en intcrinl-e\.rnt5 in pi`ripheral cases can propel share prices in one direction or an- other" (Orcv 1495, p. 7'0). The overhang of potenti,il liability cas;s a shadow on tobacco stocks. Opinions differ about just hovv much these stocks are discountecl for liability, but there is general agreement that the re- mo\.al of the liability shadow would be worth man\! billions in increased stock value. This volatile corubj- nation of possible liability and latent value means that any breach in the previously impregnable liability, ramparts ~~oulcl inaugurate a period of pronounccci instability among tobacco investors. Some analysts imagine a zone of agreement that would locate a com- prehensive settlement, which would in turn unlocl\ the unrealized value of tobacco stocks while provid- ing generously for the victims of tobacco. Howetrer, because present litigants cannot preclude future plaintiffs, it remains unclear whether litigation can provide the finality and closure that a comprehen- sive settlement would require. Litigation can set off ramifying effects and in general advance a formerlk sluggish or obstructed state of affairs, but it is not clear whether it can contain these effects or design an all-encompassing resolution or policy. Criminal Proceedings Another arena in which attention is being given to the acti\,ities of the tobacco industry is the criminal justice system. Since lYY5, the C.S. Department of Jus- tice has conducted an ongoing investigation of the al- lt>ged \.ioIation of federal criminal laws by tobacco companies, tobacco company executives, tobacco inclListr~-sLlppclrted trade and scientific associations, and other entities that have conducted business M'ith the tobacco industry. The Justice Department initiated a formal in\,es- tigation of the tobacco industry in response to the fil- ing in 1YY-l of a comprehensil~e legal analysis, referred to as a prosecution memorandum, by Representative Martin T. Meehnn (D-MA) kvith the U.S. Attorney Gen- eral (t-lohler 1YY-I; Mallory 1991, 1993; Meehan lY91; Schlvartz 1c)Y-l; Miga 1995; Reuters 1996; Rodriguez and Taylor lYY8). The prosecution memorandum pe- tition& the Justice Department to consider allegations that tobacco companies, tobacco company executi\.es, and others had \.iolated multiple criminal la\vs by pro- \-iding false information to the FDA and the U.S. Sur- geon General (18 U.S.C. section I001 ), committing perjury- in testimony before Congress (18 U.S.C. sec- tion IQ1 ), perpetrating mail and \Vire fraud (18 ti.S.C. sections 1341 and 1313, respectix.ely), engaging in de- cepti1.e ad\.ertising practices (15 ti.S.C. section 52), and \.iolating federal conspiracy and racketeering law,s (18 L .S.C. sections 371 and 1962, respecti\.ely) (Meehan 1994; Shane 1997; Cor/70r0f[~ Crirlti, Rf~prff~r 1998; Clifford E. Douglas. The criminal in\,estigation of the tobacco industry. Speech to the 13th Annual Confer- ence of the Tobacco Products Liabilitv Project; Mav 31, - 1998; Boston; unpublished data). Nature, Extent, and Focus of the Criminal Investigation The Justice Departmtnt'q in\.estigation began `as a preliminar~~ inquire focused on nlleg?d perjur\. ari>- ing out of testimonv deli\ wed under o;lth b\, Se\.t'tl :obacco comp nv execu tiws l\,ho stated before a con- gressional subc&mittee on April 14, 1994, that the\, did not believe that nicotine is addicti1.e. The initi;ll inquirv was later expanded to a formal grand jurv in- \.estigation to address broader allegations that tobacco, companies had, among other things, \iolatcd 1 S L .L;.C. section 1001. Section 1001 prohibits the making ot f,3lsc stc3tc- men& to agencies and officials of the federal go\.erii- ment (Hilts 1995; Novak and Freedman 19Y5; Appleson 1996; Blum 1996; Freedman 1996; Thomas and Sch\vartz 1996; Stohr 1 YY7). In contrast to the le\,cl of proof required for a she\\-ing of perjur); section 101) 1 does not require a sho\2%ig that a person ktio\vingl\r lied under oath. It alsoallo\vs prosecution for the witI;- holding of information. Besides addressing potential section 1001 \riolations, the in\,estigation continues to focus on other allegations of criminal conduct, includ- ing fraud, conspiracv, and racketeering (Cole and Tay- Ior 19%; Car-pwatr Ct'irw Rcprfcr 1998; Da\,is and Duff! 1998; Douglas, unpublished data; Duffy and Taylor 1998; Meier 1998~). As of mid-1998, txvo federal grand juries \vere con- sidering evidence of alleged tobacco industry \vrong- doing. One grand jury was assigned to hear evidence presented by prosecut& from the Fraud Section of the Justice Department's Criminal Division regarding the broad allegations of criminal misconduct described abo\,e. The second grand jurv \\`as assigned to review information presented bv the b.5 attornev for the East- ern District of Ne\v York: The \vork of thesecond grand jury concerned a related criminal in\Testigation Lvhose focus is an alleged conspiracy by major tobacco manu- facturing companies to suppiess legitimate medical re- search and promole biased research through the itldustrv-sponsored Council for Tobacco Research. The Justice department coordinated these complementar); investigations (Cohen and Gevelin 1996; Thomas and Schrzartz 1997; Da\,is and Duf;v 19%). A third criminal investigation was begun in 1995 to determine \vhether a major cigarette manufacfur- ing company may have committed securities fraud by failing to disclose all it knew about nicotine. Under securities lal\-s, companies are required to disclose sig- nificant information that may affect their stock price. The third in\.estigation was initiated by the U.S. attor- ney for the Southern District of New York, following the publication of an investigative news article that reported that, based on a revie\\r of 2,000 pages of pre- \-iwtsl\, undisclosed documents, Philip Morris Com- panic; Inc. had conducted many years of secret rescarih into the pharmacologic effects of nicotine on the hut31~3n brain and central nervous system (Freed- man and Lambet-t 1995; Hilts and Collins 1995). The securities frc3~td in\.estigation subsequently was con- \olidated \\.ith the main Justice Department investi- gation (Philip Morris Companies Inc. 1998). Federal prosecutors have interviewed witnesses, compiled comprehensi\-e company dossiers, and is- suej subpoenas, all under the supervision of the U.S. .Attorne\. General. Selw-al of the major cigarette manu- tdituriiig iomptiies, such as R.J. Revnolds Tobacco Cornpan!. and Philip Morris Companies Inc., as well as others, confirmed publicly that they are the subject of Wet-al criminal investigations relating to the mat- ters described abo1.e and that employees of the com- panies ha\,e recei\.ed requests for information, including orders to produce internal documents and subpoenas to testify before the grand juries (Goshko 1995; Hilts 1995; Miga 1995; Associated Press 1996a,b; Bloomberg Business Nexus 1996a,b; Federal Filings- Do\\ Jones Nc\z,s lW6; Johnston 1996; Jones 1996; Reuters 1996: Thomas and Schwartz 1996; Tribune Ke1z.s Ser\,ices 1996; Weiser and Schwartz 1996; Shaffer 1997; Philip Morris Companies Inc. 1998). In an April 1998 announcement that it had reached a cooperation agreement with a cigarette manufacturing company in support of the criminal in\,estigation, the Justice Department identified five main subject matter areas on which it was focused (U.S. Department of Justice 19%). These were industry kno~~ledge of the health consequences of smoking cigarettes and the addictive nature of nicotine; the tar- geting of children and adolescents by the industry; the manipulation of nicotine by the industry; control of research by the Council for Tobacco Research, includ- ing special projects conducted under the auspices of the council; and la\v);er involvement in directing re- search or crafting false or misleading statements by any of the tobacco ckmpanies to the Congress, the FDA, and the American consumers concerning the above. The announcement ot the cooperation agreement leas interpreted by legal experts as a sign that the crimi- nal inr,estigation \vas accelerating and the Justice De- partment \vas likely lo file broad conspiracy charges against major cigarette companies in the future (Cole and Taylor 19%; Cor/wrufv Crir~rc Rqwrfcv, IYY8; Dou- glas, unpublished; Duffc and Tavlor IYYK; Keil 1YY8; Lwin and Ostrotz. 1998;~Sch~vart; 1998a). Key Sources of Evidence The gathering of evidence by the Justice Depart- ment was advanced by the increased availability of an array of outside resources. These included the results of the exttnsi\re in\,estigation of the tobacco industrv conducted by the FDA from 1991 to 19%. The FDA's administrative record and investigative files lyei-e made al.ailable to the Justice Department, pro\.iding prosecutors and in\.estigators w.ith a significant hod! of information concerning tobacco manufacturers' knowledge of the addicti1.e nature of nicotine and of the manipulation and control of Ihe substance (Fc~l~~r-~rl RC~ijff'f 1995b, lYY6). I Another important source of information for JUS- tice Department officials \vas the \.oluminous hearing record procluced o\.er a l&month period in IYYJ bv the Subcommittee on Health and the En\~ironment &f the Committee on Energy and Commerce in the U.S. House of Representati\.es (19Y5a,b,c,d). The subcom- mittee, chaired bv U.S. Representati\,e t-lenr!, A. Waxman (D-CA), yield numerous hearings in \\.hich testimony \vas obtained from a \-arietv of ~vitnesscs, including the commissioner of the FDA, other federal government health officials, experts in nicotine addic- tion, tobacco company representati\ es, and former tobacco company scientists, among many othc23. In addition, Representative lVaxman made available bun- dreds of prer-iously secret nicotine research docume:i ts from the largest cigarette manufacturer by reading them into the public record on the floor of the House of Representatives in Julv 1995 (Associated Press 1995; C~~)~gw.ssio,lr~/ RrTiclr[l lYY%a,b; Schlz-artr lY)c)5). A third significant source of e\,idence in suppwt of the Justice Department's criminal inx~esfigation lvas the emergence of internal tobacco companvhx- ments and testimonv obtained in pri\,ate lal\.suits brought against tobacco industry defendants. Start- ing in 1994, these civil cases xvere initiated by state at- torneys general, private classes of allegedly addicted and injured smokers, and individual plaintiffs, as de- scribed earlier in this chapter (see "The Third Wa1.e of Tobacco Litigation"). The simultaneous litigation of numerous civil suits and the Justice Department's pursuit of its criminal investigation have produced a notable synergy. Millions of pre\riously undisclosed tobacco industry documents that were obtained through the discovery process in civil lawsuits became, in many instances, readily accessible to federal pros- ecutors (Curriden and Rodrigue 1997; Geyelin 1998; Meier 1998~; Rodriguez and Taylor 1998; Scherer and Ryba k 1998; Schwartz 19%~). Initial Results of the Criminal Investigation The Justice Department's ongoing investigation resulted in a first conviction in 1998. Under the terms of an agreement with the government, a biotechnol- ogv company, DNA Plant Technology Corporation, pliaded guilty to a misdemeanor charge of conspir- ing to break a law that had made it illegal to export tobacco seeds. The company was found to have cl>- gaged in such unlawful conduct in cooperation with a leading cigarette manufacturing company, identified as an unindicted coconspirator, with whom it had contracted to patent and develop a genetically altered tobacco code-named k-l, M-hich contained appioxi- mately twice the nicotine of ordinary tobacco. Accord- ing to the Justice Department, the prosecution memorandum submitted by Representative Meehan, and the FDA, one of the goals of the cigarette con- pany in conspiring with the biotechnology company ~\`as to de\,elop a reliable source of supply of high- nicotine tobaccos that could then be used to control and manipulate the nicotine levels in several popular cigarette brands (Meehan 1991; Failers/ Rqi.sfcr 1995b, 1996; Meier 1998d; Neergaard 1998; Schwartz 199Pb; Schn'artz and Connolly 1998; Taylor 1998; Taylor and Rodriguez 19%; Weinstein 1998b). Beginning in 1997, the threat of criminal liability led certain individuals associated lvith the tobacco in- dusty, such as Thomas S. Osdene, Ph.D., former Di- rector of Research for Philip Morris Companies Inc., and Roger R. Black, current Director of Leaf Blending for Bran-n & Williamson Tobacco Corporation, to decline to anslver questions under oath, choosing instead to invoke the Fifth Amendment right against self-incrimination (Gevelin 1997; Meier 1997; Weinstein 1997a; Anderson 1998). Some officials sought immu- nity from prosecution in exchange for their coopera-- tion. Such offers \vere met with mixed responses from the Justice Department. Typically they were rejected, but in one publicized instance a request for immunity \vas granted (Geyelin 1997; Stohr 1997; Weinstein 1997a). The Justice Department granted immunity to Janis A. Brax.0, a scientist formerly with DNA Plant- Technology Corporation and coholder of the patent for a high-nicotine tobacco plant called Y-l, del,eloped for Bro~-n & Williamson Tobacco Corporation. prognosis for Future Actions Through the Criminal Justice Process Federal prosecutors possess considerable discre- tion both in terms of bringing charges against alleged r2-rongdoers and, in the t\rent a strong case is dew- aped, in seeking concessions from criminal targets in the plea-bargaining process. In light of these options, the Justice Department may seek to require tobacco manufacturing companies to modify their ad\,ertising ancl marketing practices so as to render them unap- pealing to young people, stop manipulating nicotine or using nicotine-enhancing chemicals, pay the fed- eral government significant monetary penalties, and submit to regulation by the FDA (C~/X~JX~~~ C~irlw RI,- IwrYtlr 1998; Douglas, unpublished data ). Gi\ren the breadth and complesity of the crim- nal investigation of the tobacco industry, as \vell as the substantial burdens of proof that prosecutors must satisfv pursuant to the federal criminal statutes noted abov;, it is not possible to predict the outcome of the current criminal investigatik.e process. From its incep- tion, the investigation \vas anticipated to be a lengthy, complicated operation, in part because of the government's responsibilitv to process and re\.itw millions of pages of documents obtained from the to- bacco industry and other sources (Thomas and Schwartz 1996). With the Justice Department's accumulation of a growing bodv of evidence, including company documents and-grand jury testimony, as well as the cooperation of the Liggett Group Inc. in support of the government's investigation, some legal experts have described the investigation as likely to result in further action (Cole and Taylor 1998; Cor/~or,atc CrirlltT Reporfr~ 1998; Douglas, unpublished data; Duffy and Tavlor 1998; Keil 1998; Levin and Ostrow 1998; Schwartz 1998a). One recent indicator that the issu- ance of indictments might be near was the delivery by Justice Department officials of letters to Brown & Williamson Tobacco Corporation and its officials, for- mally notifying them that they are the targets of a criminal investigation and that they face possible prosecution (Davis and Duffv 1998; Meier 1998~; Milrll ' Stwrf ~ollrr?n/ 1998). Further criminal action against the tobacco in- dustry also raises the likelihood of diluting the influ- ence of the industry's political lobby, thereby strengthening the abilitv of public health proponents to advocate for more `stringent regulation of the manufacture, sale, distribution, advertising, and pro- motion of tobacco products (Douglas 1998). Comment After 40 years in lvhich two waves of product liability litigation proved unavailing, there has been a recent upsurge of in\,estment and innovation in to- bacco litigation. This third \vave of litigation departs from its predecessors in various wavs: . It mo\`es away from exclusi\,e reliance on smokers as plaintiffs, because so many cases have been de- cided against them as the victims of their own, in- formed behavior choices. Plaintiffs now include states, cities, pension funds, priaiate health care pro- \,iders, and persons exposed to ETS, none of whom can be blamed for smoking in the face of warnings. o It multiplies the range of legal issues. Instead of focusing exclusively on common-law tort doctrine, third-\va\~e litigation also invokes various statutory claims under consumer, antitrust, and other pro- tecti1.e legislation. o It expands from the classic private lawsuit by a dis- crete plaintiff to the class action device. o It expands from solely seeking monetary damages to including claims for injunctive relief, medical monitoring, and the recovery of attorneys' fees. o It shifts from a pure model of private law to mixed strategies in lvhich private law is used to effectu- ate public policy by defending public fiscal inter- ests and by enhancing the performance of statutory and regulatory controls of tobacco. . It enlarges the roster of claimants' lawyers from those M'ho specialize in representing individual plaintiffs in personal injury cases to include mass tort specialists and entrepreneurial securities class action 1aMyers. These attorneys, who typically practice in larger firms than individual plaintiff at- torneys and have greater financial resources, are joined in more complex coalitions, including alli- ances M'ith government lawyers. Considerable uncertainty surrounds each of the several third-wave litigation initiatix-es and their potential contribution to reducing tobacco use. The prospect of using private law in these ways has cap- tured attention only recently. In a wide-ranging 1993 revie\\, of tobacco policy (Rabin and Sugarman 1993), virtuallv all of the attention to private law was devoted to smokers' product liability litigation. The ne\ver le- gal theories that are no~v a\.ailable to plaintiffs have considerable potential. Just ho\~ these initiatives will fare depends both on developments within the legal system and on forces outside it. Normally, la\z incorporates and reflects public opinion. In a setting Mhere smoking declines and be- comes disreputable, particularly among the educated and influential (Zimring lYY3), where smokers are in- creasingly \,iewed either as victims of coercion and addiction or as a minority group becoming more dis- tanced from others (Gusfield lYY3), and where evi- dence accumulates that the tobacco companies aggressively recruit new smokers and suppress knowl- edge of harmful effects of smoking, the law can be ex- pected to respond to pressures to extend accountability and to provide remedies, if not to smokers then to those who are otherwise adversely affected by smoking. However, other forces are working against an enlarged role for the civil justice system in the effort to reduce tobacco use. Important groups, displeased with the expansion of legal accountability, hai.e mounted a protracted and influential campaign to curtail the civil justice system and \\Teaken the position of claimants within it (Galanter 1993, 1994). Apart from these ex- ternal constraints, the \Tery magnitude of tobacco injurv-the vast number of potential claimants involved-raises apprehension about the courts' in- stitutional capacities to respond. Driven by the desire to conserve their scarce resources, courts \vill find \vavs to ration the judicial attention bestolled on any & able set of related cases (Sanders 1992). As the size of the potential victim class increases, the chances tor individualized judicial resolution clecrease. It has been argued that the litigation about Agent Orange, the Conclusions Bhopal disaster, and asbestos-related injury should be viewed as instances in which the sheer number of claims "simply overwhelm[edl the capacity of legal institutions to meet victim compensation needs" and led to improvisation of formulaic administrative solu- tions (Durkin and Felstiner 1994, p. 159; cf. Henderson and Twerski 1991, on judicial aversion to such mas- sive projects). A balanced assessment of the possible contribu- tion of private law initiatives to the effort to reduce tobacco use must consider not only the costs and ben- efits of the various initiatives but also the likelihood of accomplishing similar results by other institutional means (Komesar 1994). Typically, private law involves high transaction costs (Galanter 1994). Private law is by definition the creature of independent actors whose operations are not centrally managed and are at most partially and intermittently coordinated; each actor is trying to maximize its own gains as it defines them. No single initiative or the sum of such efforts will nec- essarily produce an optimal policy to reduce tobacco use. Yet private law may be a valuable component in reducing tobacco use precisely because it is an arena in Mhich multiple courses of action are advanced bv energetic champions who are open to new ideas ani ~.ho, independent of government, can undertake in- novative and even risky initiatives without securing official approval or competing for priority with other political commitments. Such initiatives may thus be able to stimulate and shape policy solutions. Other than as an agent or catalyst, however, it seems unlikely that the judicial forum, in a setting involving politi- calls powerful actors and an unpredictable number of inclioate future claimants, will itself provide the ulti- mate policy resolution. Aduertisiug and Promatiou 7. Since 1964, numerous attempts to regulate ad- vertising and promotion of tobacco products have had only modest success in restricting such activity. 7 &. Current regulation in the United States is con- siderably less restrictive than that in several other countries, notably Canada and New Zealand. 3 . Current case law supports the contention that ad- LJertising does not receive the protections of free speech under the First Amendment to the Con- stitution that noncommercial speech does. Product Regdrztiorr Minors'Access to Tobacco 1. Warning labels on cigarette packages in the United States are lveaker and less conspicuous than those of other countries. 7 -. Smokers receive very little information regard- ing chemical constituents when they purchase a tobacco product. Without information about toxic constituents in tobacco smoke, the use of terms such as "light" and "ultra light" on pack- aging and in advertising may be misleading to smokers. 3. Because cigarettes \vith 10~. tar and nicotine con- tents are not substantiallv less hazardous than higher-vield brands, co&umers may be misled by the implied promise of reduced toxicity un- derlying the marketing of such brands. 4. Additives to tobacco products are of uncertain safety Cohen used in tobacco. Kno\vledge about the impact of additi\,es is negligible and lvill remain so as long as brand-specific information on the identitv and quantitv of additives is unavailable. . 5. Regulation of tobacco product sale and promo- tion is required to protect young people from in- fluences to take up smoking. Clear1 indoor Air Regulation 1. Although population-based data sho~v declining ETS exposure in the workplace over time, ETS exposure remains a common public health haz- ard that is entirely preventable. ? -. Most state and local laws for clean indoor air re- duce but do not eliminate nonsmokers' exposure to ETS; smoking bans are the most effective method for reducing ETS exposure. 3. Beyond eliminating ETS exposure among non- smokers, smoking bans have additional benefits, including reduced smoking intensity and poten- tial cost savings to employers. Optimal protec- tion of nonsmokers and smokers requires a smoke-free environment. I. Measures that have had some success in reduc- ing minors' access include restricting distribu- tion, regulating the mechanisms of sale, enforcing minimum age laws, having civil rather than criminal penalties, and providing merchant edu- cation and training. Requiring licensure of to- bacco retailers provides both a funding source for enforcement and an incentive to obey the law \2Then revocation of the license is a provision of the 1aM. 3 -. The effect of reducing minors' access to tobacco products on smoking prevalence requires further e\,aluation. Litigation Apyronches 1. Tlz-o historic \vaves of tobacco litigation were ini- tiated by private citizens, were based largely on theories of negligence and implied warranty, and 17ere unsuccessful. 7 A. A third \va\`e has brought in new types of claim- ants, making statutory as well as common-law claims and using more efficient judicial proce- dures. Although several cases have been settled for substantial money and have yielded public health provisions, many other cases remain un- resolved. 3. Private law initiative is a diffuse, uncentralized activity, and the sum of such efforts is unlikely to produce optimal results for a larger policy to reduce tobacco use. On the other hand, the liti- gation actions of individuals are likely to be a valuable component in some larger context of strategies to make tobacco use less prevalent. Abramson J. Tobacco industry steps ~tp flow of catw paign money. NL~ ki~rk Tiirrcs, Mar 8, 1998; Sect 1:l (co1 5). As~I~s, f,rc. ~7. Ahtt~, 710 A.2d 914 (Md. Ct. Spec. App. 1998). Adkins LW. A Minnesota councilwoman's crusade to ban cigarette machines. rZLlil'c,L'k'i Markt>tir~~q Wwk 1989;30(43):2. Alexander HM, Callcott R, Dobson AJ, Hardes GR, Lloyd DM, O'Connell DL, Leeder SR. Cigarette smok- ing and drug use in school children: IV-factors asso- ciated \lith changes in smoking beha\iour. l~tfc'rllnfi~~lwl /u~fr!ud of t`[JiifCH?iO/tJ$,l/ 1%+3;12(1):5'?-66. Alm B, Milerad J, Wennergren C, Skjaeri,en R, Oyen N, Norvenius G, Daltveit AK, Hellveg-Larsen K, Markestad T, Irgens LM. A case-control study of smoking and sudden infant death syndrome in the Scandina\?an countries, 1992 to 1995. The Nordic Epi- demiological Study. Arilrl'i~c~s 0f Diwl.w irl Ci?i/[lrc,rl 1998;78(4):329-34. Altman DG, Carol J, Chalkley C, Cherner J, DiFranza J, Feighery E, Forster J, Gupta S, Records J, Slade J, Talbot B, Tye J. Report of the tobacco policy research study group on access to tobacco products in the United States. Ptxx-co Cnr~trwl 1992;l (Suppl):S35-S51. Altman DC, Foster V, Rasenick-Douss L, Tye JB. Re- ducing the illegal sale of cigarettes to minors. /o/lrrlnl of fh Amcuict~r~ MtIiiical &wiafiorl 1989;261(1):80-3. Altman DG, Rasenick-Douss L, Foster V, Tye JB. Sus- tained effects of an educational program to reduce sales of cigarettes to minors. Americnr~ /arrnnl ofPublic Fhltlz 1991;81(7):891-3. Altman DG, Wheelis AY, McFarlane M, Lee H, I Fortmann SI? The relationship between tobacco access and use among adolescents: a four community study. Social Scitp~~ce &- Medicirw 1999;48(6):759-75. hwricntz Adswfisi~~g Fc&ratiorr zl. Kessler, Civil Action No. 2:95CVOO593 (M.D.N.C. Aug. 10,1995), cifpd ~JI 10.5 TPLR 3.401 (1995) (Complaint for Declaratory Judg- ment and Injunctive Relief). American Health Foundation. Corunrtvzts OII Tubncco Atftfitizw. Valhalla (NY): American Health Foundation, 1990. American La\%, Institute. R~sfnft~nrtv~f ufth Law (Third). fijrts: Pmfucts Linllilify. Tentative draft no. 2, 5 2: cat- egories of product defect. Philadelphia: American La\\ Institute, 1993:12-127. American Medical Association House of Delegates. Rqwrf of Rt~ft~rtvlrt~ Coruruiftce D. Chicago: American Medical Association, 1995. American Pharmaceutical Association. Professional Affairs. 2. Smoking and health. ]otlrrznl L7ffl7e Amcricnrr Pl~h~~~~n~~~~~fiC~71 Associnfiorz 1971;NSll(5):270-1. Anderson C. Sealing refused for deposition in tobacco case. Nw Lijvk Lnsl ]o~rrrzrrl, Feb 2, 1998:l(col 3). Anderson HR, Cook DG. Passive smoking and sud- den infant death syndrome: review of the epidemio- logical evidence. Thorax 1997;52(11):1003-9. Andrews JL Jr. Reducing smoking in the hospital: an effective model program. Chest 1983;84(2):206-9. Appleson G. Harley-Davidson, Man\.ille unlikely pair in tobacco lvar. Rc~rtrr B~rsirw+ Rc/~r)r?, Mar 23, 1995. ,-1\,ailable from Dialog(R)F 611:Reuters. ,\ppleson G. Justice shifts focus of tobacco probe: source. Reuters (news Loire), July 11, 1996. Associated Press. Tobacco studies detailed. ~"V'C~:P 1ilr!i Ti~w, JLI~~ 25, 1995;Sect B:7. .Associated Press. Philip Morris alerts emplovees to government probe. Apr 6, 1996a. Availablt from Dialog(R)F 258:Associated Press. Associated Press. Report: Philip Morris esecuti\,es sub- poenaed. Aug 29,1996b. Available from Dialog(R)F 258:Associated Press. +.ssociated Press. Judge orders fi1.e California tobacco larvsuits consolidated for trial. Jul\. 21,lYYti. A\.ailable from Dialog(R)F 258:Associatei Press. :iustralian Ne\ys Network. Smoking council \2-elcomes court decision. T/w Austrnlior~, Julv 24, 1998. Kr7dillo i'. Auit>l.itmtl Tohiro Co., No. CV-N-97-00573 DWH (D. Nev. 1997). Rqgeft cl. Sutlwlmi, No. CA 88-224, 1989 \/vL 5399 (Ark. App. Jan. 25, 1989). Baile WF, Gibertini M, Ulschak F, Sno\v-Antle S, Hann D. Impact of a hospital smoking ban: changes in tobacco use and emplovee attitudes. Alldictiw B&z'- /or.5 1991;16(6):419-26. . Bn~~hnf 71. FCC, 405 E2d 1082 (D.C. Cir. 1968), r-c')+ rlf,- rlirti, 396 U.S. 842, 90 s. Ct. 50 (1969). Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. jo~~rrml of f/w hwicnu Medic-rrl Associafiorl 1998;279 (19):1466-70. hrr~t~ il. A/trc7,,iiflil ~hflico CO., NO. 96-5903 (E.D. Pa. Aug. 22, 19971, vacated 176 F.R.D. 479 (1997), cifed i?z 12.1 TI'LR 2.227 (1997). Becker DM, Conner HF, Waranch HR, Stillman F, Pennington L, Lees I'SJ, Oski F. The impact of a total ban on smoking in the Johns Hopkins Children's Cen- ter. ]o~~.rlnl c~f t\w A~rc~ricnrl Mdicnl Associntior~ 1989; 262(6):799-802. Beede I', Lal~son R. The effect of plain packages on the perception of cigarette health warnings. Public Hcl7ltl7 lYY2;106(43:315-22. Benowitr NL, Hall SM, Herning RI, Jacob P III, Jones RT, Osman A-L. Smokers of low-yield cigarettes do not consume less nicotine. hi~wl Er~~~/n~lil /olrrrwl CJ~ Mrdi- iiricl 1983;309(3):139-42. Beno\vitz NL, Henningfield JE. Establishing a nicotine threshold for addiction: the implications for tobacco regulation. Nw Erl~ln,zil jolrrlwl of Meiiicirw 1994;331(2): 123-5. Benolvitr NL, Pinney J. Nicotine preparations in smok- ing. In: Korting HC, Shafer-Korting M, editors. T/w Bcrlc~fit/Rijk Rntir~: A ~~7~7d~JOOk f@!' f/l? Raji~fln/ Use 0f Pof~~rzti~7ll~/ Hazn,~llolr~ Dr!rg.s. Boca Raton (FL): CRC Press, 199X:307-18. Bernstein Research. Tobacco litigation: turbulence ahead, but stocks still overdiscounting risks. Reiterate outperforms [memorandum]. New York: Sanford C. Bernstein & Co., Oct. 12, 1994. Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. jo~rrrnl o,f f/7~ Amcri- cl7!7 Mtdiml i2mcinfior1 1994;271(8):612-7. Biener L, Abrams DB, Follick MJ, Dean L. A compara- tive evaluation of a restrictive smoking policy in a gen- eral hospital. Am~icnr7 Jourr~nl of Public Hmlfh 1989; 79(2):192-Z. RjL~f710i11 7'. Vir;yijlif?, 521 U.S. 809 (1975). Blasi V, Monaghan HP. The First Amendment and ciga- rette adlrertising. ]o//rjw1 c$ f/w Aj~c>r,icnlj Mcdirnl Asso- cir7ticur lYXh;256(1):50-9, Bloomberg Business News. Philip Morris employees get subpoenas. RitTzll I'(]& Tirr~cs, Sept 4, 1996a;Sect D:2. Bloomberg Business News. Philip Morris executives ordered to testify before a federal jurv. Riczcl I'& Tinw, Aug 31, 1996b:22 (co1 5). B/W cross alrd Blue Shield of Neicl Jcrscy ~1. Philip Movris (E.D.N.Y. Apr. 29,1998), cifed i/l 13.2 TPLR 3.51 (1998). Blum A. Justice Dept. reportedly changes tack vs. to- bacco. hinfior~nl Lazl1 Jo~lrr~nl. Sept 16, 1996;Sect A:7. Board of Tr1rsfecs C)f the state U17iiwsify of New York i'. Fox, 492 U.S. 469 (1989). Boddewyn JJ. There is no convincing evidence for a relationship between cigarette advertising and con- sumption. British \@I/YJI~~I of Arftlictior~ 1989;84(11): 1255-61. Borland R, Chapman S, OIven N, Hill D. Effects of workplace smoking bans on cigarette consumption. Amvk-n~~ ]~w,id of Pub/ii Hmlfh 199Oa;80(3):178-80. Borland R, Owen N, Hill D, Chapman S. Changes in acceptance of bvorkplace smoking bans follo\ying their implementation: a prospective studs. Prwfvftiiv~ Mrdi- cI)~c 1990b;19(3):314-22. Borland R, Orven N, Hocking B. Changes in smoking beha\riour after a total rvorkplace smoking ban. .41/s- tralian ]o~fiwnl of Puldic Hci7lti7 1991;15(2):130-4. Borland R, Pierce JP, Burns DM, Gilpin E, Johnson M, Bal D. Protection from en\.ironmental tobacco smoke in California: the case for a smoke-free \vorkplace. ~ourrzal of the .4n~erici7r? Medical Assoc-iaticul 1992;268(6): 749-52. Bourque K. Union pension funds and asbestos com- panies join in fight against tobacco companies. T~11~17cco on Trial 1997:6:6-9. Boyse S. Note on a Special Meeting of the UK Industry on Environmental Tobacco Smoke, Feb 17, 1988, London;; accessed: February 15,1999. Brenner H, Mielck A. Smoking prohibition in the work- place ,md smoking cessation in the Federal Republic of Germany. Pv~ocrllive Medicirze 1992;21(2):252-61. Breo DL. Kicking butts-AMA, Joe Camel, and the "black-flag"war on tobacco. Jolrvnal of tlzc Atuerica~~ Medica/ Associatim 1993;270(16):1978-84. Bridges RB, Combs JG, Humble JW, Turbek JA, Rehm SR, Haley NJ. Population characteristics and cigarette yield as determinants of smoke exposure. Pharmacal- ogy, Bioclrrrnistry ar?d Behavior 1990;37(1):17-28. Broitz zl. Fhiliy Morris Cos., No. 92-1405 (Fla., Dade Cty. Mar. 15, 1994), cifd in 9.1 TPLR 2.1 (1994). Broir~ 7'. Pl7ilip Morris Cos., No. 91-49738 CA (22) (Fla., Dade Cty. Feb. 3, 1998), cited in 13.1 TPLR 2.79 (1998) (Order Granting Verified Petition for Final Approval of Settlement and Payment of Attorneys Fees and Costs by Settling Defendants and Final Judgment). Broirl z'. Philip Morris IIIC., No. 91-49738 CA (22) (Fla., Dade Cty. Oct. 9, 1997), cited in 12.6 TPLR 3.397 (1997) (Settlement Agreement). Brown LJ, DiFranza JR. Pharmacy promotion of to- bacco use among children in Massachusetts. Amrim Pharmacy 1992;NS32(5):45-8. BrOtLltI ~5 Willinumrz Tobnccn Corp. z'. Cnrtrr, No. 96-4831, 1998 Fla. App. LEXIS 7477 (Fla. Dist. Ct. App. June 22, lY98). Brrxu)l G Willion~sol~ Tobacco Car;?. z'. Food 0 Drug ,4d- nlirzistratiorl, No. 97-1604 (4th Cir. 1998). Brownson RC, Alavanja MCR, Hock ET, Loy TS. Pas- sive smoking and lung cancer in nonsmoking women. ,4~~~c~rjc11/1 /olir/~nl of Pzrb/ic &~/t/z 1992a;82(11):1525-30. Brownson RC, Davis JR, Jackson-Thompson J, Wilker- son JC. Environmental tobacco smoke awareness and exposure: impact of a statewide clean indoor air law and the report of the US Environmental Protection Agency. %&co Coiltrol 1995a;4(2):132-8. Brownson RC, Jackson-Thompson J, Wilkerson JC, Davis JR, Owens NW, Fisher EB Jr. Demographic and socioeconomic differences in beliefs about the health effects of smoking. Ameriarrr Jurtrrrul of Publir Hmlflr 1992b;82(1):99-103. Branson R. Miss. near tobacco payments should go for health. i% Cnn~r?~rri-inl Appca/, July 8, 1998;Sect B:l. Reducing Tobacco Use Brownson RC, Koffman DM, Novotny TE, Hughes RG, Eriksen Ml? Environmental and policv interventions to control tobacco use and prevent cardiovascular dis- ease. Hraltlr Etfltcnfion Qlrnrfrrl!/ 1995b;22(4):478-98. R~irkir~~har~~ il. X.1. Rcyrm1d.s Tobacco Cu., 713 A.2d 381 (N.H. 1998). Bureau of National Affairs, Inc. Cigarette maker settles FTC charges of false ads regarding health effects. .-\!I- rifrmf Ovid Trnde Rqulntinr~ Rt~pr't 1990;58(1471):964. Bureau of National Affairs, Inc. S/r~)kj/?x i/r flzo work- I~II~cL~: 1991-SHRk-BNA Slrr.~,~/ No. 375. Bulletin to Management. Washington: Bureau of National Affairs, Inc., 1991. Hufkr ~1. Anwrirn77 Tdmi-co Co. (Miss., Jones Cty. May 12, 1994), rifcll i,~ 9.3 TPLR 3.335 (1994) (Amended Complaint). HI~~[L'I. ~1. Philip Morris I77c., Civil Action No.: Y4-5-53 (Miss., Jones Cty. Mar. 4,1996), cited irl 11.3 TPLR 3.307 (1996) (Second Amended Complaint and Request for Trial by Jury). Byrd GD, Robinson JH, Cald\vell WS, deBethizy JD. Inter-individual variation of nicotine uptake among smokers. Poster presented at the International Sym- posium on Nicotine; July 21-4, 1994; Montreal. Calabresi G. TIJP Custs ofAccidents: A Lep~ IJJII~ Ecnrmmir 14rznlysis. New Haven (CT): Yale University Press, 1970. Caldwell MC, Wysell MC, Karachi I. Self-service tobacco displays and consumer theft [letter]. T&~cro Cor~tr-01 1996;5(2):160-1. California Environmental Protection Agency. H~~olfll EJfrcfs of E.r.poswe to E77i~iro77777rr1tnl Tuhncro S777okc. Fi- nal Report. Sacramento (CA): California Environmen- tal Protection Agency, Office of Environmental Health Hazard Assessment, 1997. cfllifonlifl ~1. PhikpMon'is IX., ,No. BC194217 (Calif., Los Angeles Cty. July 14, 1998), cifrd jjz 13.4 TPLR 3.195 (1998). Campbell WI. Rq~rlntioll o,f Tobnrro (Pnrt I): Heavirlgs Befow the S~rlmmnzittec~ 077 Hmlfh md the El~z~ironmetzf of thr Horrsc conrrui~trr @II Erlergy nrrd Co77rnre7'cc, 103rd Congress, 2nd Sess. 542 (1994) (statement on behalf of Philip Morris, Inc.). Cnpitol Rrmdcmti~~g Co. z'. AcfillX Affmq General, 405 U.S. 1000 (1972), otf'd sub 770777. Cnpifnl Bvondcasfirlg Co. i'. Mitchell, 333 F. Supp. 582 (D.D.C. 1971). Cardenas VM, Thun MJ, Austin H, Lally CA, Clark WS, Greenberg RS, Heath CW Jr. Environmental to- bacco smoke and lung cancer mortality in the Ameri- can Cancer Society's Cancer Prevention Study II. Cu~~ier Ci7rrws urd C~J!lff'd 1997;8(1):57-64. Carol J. It's a good idea to criminalise purchase and possession of tobacco by minors-NOT! Tohucro COJI- trr1/ lYY2;1(4):296-7. Castam il. Anw7i~r7r1 Tolwccu Co., No. 94-1044 (E.D. La. Feb. 17, lYY5), citcll ill 10.1 TPLR 2.1 (19951, vezfd 84 F.3d 734 (5th Cir. 1996). Celebrezze AJ. Agency reports. In: United States Code: Corlcqressio~u71 aj~i( Adulrrlistrntirle Ncxls. 89th Congress- Firsf Srssiarl, 1965. Vol. 2. St. Paul (MN): West Publish- ing Co., 1965:2356-61. Centers for Disease Control. Passive smoking: beliefs, attitudes, and exposures-United States, 1986. Morbid- ity f~/rrl Mar-tolity Weekly Report 1988;37(15):239-41. Centers for Disease Control. Cigarette advertising- United States, 1988. Morbidity nr~d Murtnlify Weekly RqJorf 1990a;39(16):261-5. Centers for Disease Control. Cigarette sales to minors-Colorado, 1989. Morbidity Qud Mortality w~ckly Rqort 1990b;39(44):794-5, 801. Centers for Disease Control. Evaluation of an employee smoking policy-Pueblo, Colorado, 1989-90. Morbid- ity nml Mortality Weekly Rcporf 199Oc;39(38):673-6. Centers for Disease Control. J'ublic attitudes regard- ing limits on public smoking and regulation of tobacco sales and adi.ertising-10 U.S. communities, 1989. Morbidit!/ O/I& Mar-fn/iQ h'wk/!/ R~~/wrf 1991;40(21): 344-5,351-3. Centers for Disease Control. Accessibility of cigarettes to youths aged 12-17 vears-tinited States, 1989. MOP biifity ilrrd Mortnlity L&k/y Rcpi-t 1992a;41(27):485-8. Centers for Disease Control. Discomfort from environ- mental tobacco smoke among emplovees at worksites with minimal smoking restriction&Lnited States, 1988. Morbidift/ (7r1d Mor~falif~/ Week/~/ Report 1992b; 41(20):351-1. Centers for Disease Control and Prevention. Minors' access to tobacco-Missouri, 1992, and Texas, 1993. Morbidif~~ lrrltl Mr)rfc7/ify Wwlil~/ Rc/wrt 1993a;42(7): 125-8. Centers for Disease Control and Pre\w~tion. Smoking cessation during pre\ious year among adults--United States, 1990 and 199 1. ,V!c)&litq r7/!(1 Mortality W~dl!/ Reprt 1993b;32(26):XI-l-7. Centers for Disease Control and Prevention. Attitudes toward smoking policies in eight states--United States, 1993. Mnrllillity 171711 Mortolify Wwkt~/ Rc;wrf 1YY4a; 33(13):786-Y. Centers for Disease Control and J're\.ention. Changes in the cigarette brand preferences of adolescent smokers-United States, lY8Y-lYY3. Morlliififl/ 1717d Mor- fn/ifl/ Wwk/l/ R~/wrt 1994b;43(32):577-81. Centers for Disease Control and Pre\,ention. Medical- care expenditures attributable to cigarette smoking- United States, 1993. Mort~i~fity nr~[f Morfnlify Wwkll/ Rrporf 1994c;43(26):-l69-72. Centers for Disease Control and I'rel~ention. Assess- ment of the impact of a 100'; smoke-free ordinance on restaurant sales-West Lake Hills, Texas, lYY2-19%. Mar-tlidity n/d Mortality ihJwX.1,~~ Rqwrt 1 Y9Sa;l-l( 1 Y ): 370-2. Centers for Disease Control and I'rel-ention. Trends in smoking initiation among adolescents and l~/oung adults--United States, 1980-1989. Morllilfifi/ l~r~ll Mar- fillit!/ W&/I/ RL'/JOY~ 1995b;44(28):521-5. Centers for Disease Control and Prevention. Accessi- bility of tobacco products to youths aged 12-l 7 years- United States, 1989 and 1993. Morbidity orrd Mortmlity Weekly Rqmt 1996a;45(6!:125-30. Centers for Disease Control and Prevention. Estimates of retailers willing to sell tobacco to minors- California, August-September 1995 and June-July 1996. Mar-hitiify nrrd Morfalify Weekly RPporf 1996b; 45(50):1095-9. Centers for Disease Control and Prevention. State To- IJIICCO Corztrol Hjg/rli,@zts--1996. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1996~. Centers for Disease Control and Prevention. Tobacco use and usual source of cigarettes among high school students-United States, 7995. Morhirlify~~~?d Mortality W&l!/ Rq~ort 1996d;45(20):413-8. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 1995. Morbid- if!/ 1717d Mortalify Wwk/!/ Rqmrf 1997a;46(51):1217-20. Centers for Disease Control and Prevention. Smoking- attributable mortality and years of potential life lost- United States, 1984. Mar-llidity nrd Mortnlity Week/!/ Rcpwf 1 YY7b;16(20):434-5 I, Centers for Disease Control and Prevention. Preemp- tive state tobacco-control laMs-United States, 1982- 1998. .Mor/liiIif~/ nl~[l Mar-fcllify Wwkly Rcpwf 1999; 47(51-52):1112-4. Centre for Behavioural Research in Cancer for Minis- terial Council on Drug Strategy Tobacco Task Force. fff'il/fll !`%17itlS5 17,711 CO!lff'f?t~ hhdh73 017 fih7CC~J hd- l/its. Melbourne (Australia): Anti-Cancer Council of Victoria, 1992. Centre for Health Promotion. Effccfs cf PIni11 Cignwttc I)w$;i\~,~ il,rwrr~ huflr. Toronto: University of Toronto, 1993. Chaloupka FJ, Grossman M. Price, toh~co corzfrol ~~oli- c-iil.s 171711 youth sflrokirzg. Working paper no. 5740. Cam- bridge (MA): National Bureau of Economic Research, 1996. Chaloupka FJ, facula RL. Limiting youth access fo to- bacco: the early impact of the Synar Amendment on \routh smoking. Paper presented at the Third Biennial Pacific Rim Allied Economic Organizations Confer- ence; Jan 11, 1998; Bangkok (Thailand). Chamberlain E. Philip Morris sues ABC for 510 bil- lion. T&ix (~f7 Trio/, Apr 29, lYYJ:3-5. Chapman S. Industry dolvn again dn\vn under [let- ter]. fi&7cco Cor7trd lY95;4(1 ):17-8. Chapman S. Tobacco industry memo rcx.eals passi1.c smoking strategv. Kriti5/7 Medic-nl ]c~71rr7~7I 190/;31 1 (7093):156Y. _ Chapman S, Borland R, Hill D, On.en N, Wood~~~ard S. LVhv the tobacco industry fears the passi1.e smoking issue. 1/7tc~777iltiOl7l7/ ]Olll'llili Of Ht'i71fli Sf'l.i'iiC'5 lYOO;20(3): 41 i-27. Chapman S, Wilson D, Wakefield M. Smokers' under- standings of cigarette vield labels. Mdit-[7/ /0711.7717/ of .,llisfro/in 1986;145(8):3?6, 378-Y. Cheadle A, Wagner E, Koepscll T, Kristal A, Patrich D. En\+ronmental indicators: a tool for e\,aluating com- munitv-based health-promotion programs. A77c7.ic7777 ]olirmj of Pww77fiw Meill'rirtc, 1992;8(6):345-50. Chetwynd J, Brodie RJ, Harrison 1~. The influence of adveriising on tobacco consumption: a reply to Boddewyn. Brifislr ]0111.7701 of Arldicfiorl 1989;84(11): 1263-j. Cl7iglo ~1. City of Prcstm, 9OY E Supp. 675 (D. Minn. 1995). Chr&ien J. Gozvrr7777~~~7f Actio~~ P/1717 OII S7~77rg~qli77~y. Ottawa (Canada): Office of the Prime Minister, House of Commons, 1994. Cismoski J. Blinded by the light: the folly of tobacco possession laws against minors. Wiscor7sirr Akdiiirl~17117~- 77lll 1994;93(11):591-8. Cismoski J, Sheridan M. Availability of cigarettes to under-age vouth in Fond du Lac, Wisconsin. Wisn~w si77 Medirn/)n~ml 1993;92(11):626-30. Cismoski J, Sheridan M. Tobacco acquisition practices of adolescents in two Wisconsin communities. Wisco77- 5i17 Mc~ifiihl ]077r77fll 1994;93(11):583-91. Cl\mer A. Addiction center sees Medicare imperiled b!r-rising bill for smoking and drinking. Nw yuior-k Ti~rcs, Mav 17, lY9-i;Sect A:14 (co1 1). Coalition on Smoking OR Health. Classification of low tar and 101~ nicotine cigarettes as drugs under the Food, Drug and Cosmetic Act (petition before the Food and Drug Administration). Washington: Apr 25, 1988. Coalition on Smoking OR Health. Classification of all cigarette products as drugs under section 201 of the Federal Food, Drug, and Cosmetic Act (petition be- fore the Food and Drug Administration). Washington: Mar 7, lYY4a. Coalition on Smoking OR Health. Stntc Lcgi';Iflfcil Ac- fi~r/r.> 077 ~hr~-c-o I~-I,P~. Washington: Coalition on Smok- ing OR Health 19Y4b. , Coffee JC Jr. Understanding the plaintiff's attorney: the implications of economic theory for private enforce- ment of la\v through class and derivative actions. C~~lr7777/~in Law Rwirxl 1986;86(May):669-727. Coffee JC Jr, The regulation of entrepreneurial litiga- tion: balancing fairness and efficiency in the large class action. Ulfiwrsi(t/ of C17imcqcl Lm RCD~P 1987;54(Sum- mer):877-937. Cohen JB. Research and policy issues in Ringold and Calfee's treatment of cigarette health claims. \o~~P~z~/ of Plllllic Policy 1717d Mnrkctir7g 1992;11(1):82-6. Cohen JB. Consumer/smoker perceptions of Federal Trade Commission tar ratings. In: The FTC Cigarefte Test M~~thod joI- Drf~7~77i~7i77g Tir, Nk-nfi~~, nr7d Cnrbm Mo~7osidc %>lils of U.S. CiSarl'ttcs. Report of the NCI Ex- /VI? Pn~wl. Smoking and Tobacco Control Monograph No. 7. Bethesda (MD): US Department of Health and Human SerxTices, Public Health Service, National Institutes of Health, National Cancer Institute, lYY6:127-34. NIH Publication No. 96-4028. Cohen LP, Geyelin M. Probe reopens into nonprofit tobacco group. Wnll Street /o~~rrud, Feb 8,1996;Sect A:3. Cole J, Taylor J. Liggett to cooperate in tobacco probe. Wc7ll Stwt~f /011~7~7l, Apr 29, 1998;Scct A:3. Collins C. l'apw maker to spin off tobacco units. Ntw Ywk Tirm~, May 10, 1995a;Sect D:l (co1 5). Collins G. Teen-agers and tobacco: the reaction; com- panies sue to prevent control of cigarette sales. N~lio Yc~rk Tiflws, Aug 11, 1995b;Sect A:18 (co1 5). Collins G. Tobacco suit's plaintiffs suffer a court set- back. Nw York 7`i/lrc,s, May 16, 1995c;Sect D:l (co1 2). Cnugressioml Record. 104th Gong., 1 st Sess., 1995a, 141 :H7470-H7476. Corrgrc5siorral Record. 104th Gong., 1st Sess., 1995b, 141:H7646-H7683. Conlisk E, Siegel M, Lengerich E, Mac Kenzie W, Malek S, Eriksen M. The status of local smoking regulations in North Carolina folloiving a state preemption bill. ]o~m~l of 117~ AIIIU;SIII~ Medirlrl Assoiiafiorl 19%;273 (10):805-7. Co77/7rrfir7if il. Philip Mwris IRK., No. CV 9601534105 (Corm. Oct. 9, 1996), citr~if ill 11.7 TI'LR 2.238 (1996). Connolly GN. The marketing of nicotine addiction by one oral snuff manufacturer. rC)Oflccc~ Cof7tml 1995; 4(1):73-Y. Cor~rmr 7'. X.1. Rqr7olds Tutmio Co., No. 95-01820~CA, Div. CV-H (Fla. Cir. Du\.al Cty. May 5, 1997) (jury \`er- diet for defense). Cooper H. Tobacco litigation: a comparati\,e analysis of the United States and European Community ap- proaches to combatting the hazards associated rl-ith tobacco products. Biookl!/~l lorlrrral c$ I77tn,rrlrfic,7717/ Lm~ 1990;16(2):275-303. Co7yo1.17f~~ Crier Rcprfcv~. Indictments against tobacco companies, executives to be handed down Lvithin months, Douglas predicts. Co~[~omtc' C7'ir77c kp~~t'f~7 1998;12(19):1, 12-16. Cotton I? Tobacco foes attack ads that target women, minorities, teens, and the poor, ]OUIYUI~ of !/I? AHW~M/I M~`dim1 Associnfiorz 1990;264( 12):1505-6. Coughlin PJ; Janecek FJ Jr; Milberg, Weiss, Bershad, Hynes & Lerach LLI? A Review of R.J. Reynolds' In- ternal Documents Produced in Marq-itzi us. R.]. Rcyr7oltis TtJbm-~~ Cwz/`fl/ly, Civil Number 939359-The Case that Rid California and the American Landscape of "Joe Camel"; ; accessed: February 18, 1999. Coultas DB, Stidley CA, Samet JM. Cigarette yields of tar and nicotine and markers of exposure to tobacco smoke. Americn)l Reuieur of Respiratory Disease 1993;148 (2):435-40. Council Directive 90/239/EEC of 17 May 1990, 1990 officifl/ ~(JlW77d offhe !%f'CJ/JPfUZ Conll?lur?ify (L 137) 36. Council Directive 92/41/EEC of 15 May 1992, 1992 Official ]oma~ of f17c Euroyenn Col?zmunity (L 158) 35. Coyr7e~ R~d7777, Ix. P. Food md Drug Adn7i~~istratior7, No. 2:95CVOO591 (N.C. Aug. 10, 19951, cifed in 10.5 TPLR 3.379 (1995) (Complaint). Coytrc> Benhtu. 177~. c U.S. Food 6 Drug Adnzitlisttvtiou, 966 F. Supp. 1374 (M.D.N.C. 1997). Cummings KM, Coogan K. Organizing communities to prevent the sale of tobacco products to minors. 111~ fcr.rfilfior7n/ Q7rarfrr/y ~,f Commurlify Health Edl~cntior~ 1992-93;13(1):77-86. Cummings KM, Hyland A, Saunders-Martin T, Perla J, Coppola PR, Pechacek TF. Evaluation of an enforce- ment program to reduce tobacco sales to minors. Ameri- cc777 ~07rrr7nl of Public Henlth 1998;88(6):932-6. Cummings KM, Markello SJ, Mahoney M, Bhargava AK, McElroy I'D, Marshall JR. Measurement of cur- rent exposure to environmental tobacco smoke. i\r- C/I;ZW of E~7i~im7mer7fal Hrnltlr 1990;45(2):74-9. Cummings KM, Pechacek 7, Shopland D. The illegal sale of cigarettes to US minors: estimates by state. At7wricnrz Jwrr7nl qf P~rblic Healfh 1994;84(2):300-2. Cummings KM, Saunders-Martin T, Clarke H, Perk J. Monitoring vendor compliance with tobacco sales laws: payment vs no payment approaches [letter]. An7cvicar7 ]ozrr-77cd (Jf Public Hcolfh 1996;86(5):750-1. Cummings KM, Sciandra E, Pechacek TF, Orlandi M, Lynn WR, for the COMMIT Research Group. Where teenagers get their cigarettes: a sur\`ey of the purchas- ing habits of 13-16 year olds in 12 US communities. fiJhCC0 Cor~trd 1992;1(4):264-7. Cummings KM, Vito D, Gabrel C. Tobacco, alcohol, and other drug use behaviors among adolescents in Erie County, Ne\v York. /olrr,rlfll c$ P~blii H~wltlz Mi7)1- n,ymwt Pm-fiCC 1995;1(2):23-30. Curriden hLI. Hurdle cleared for tobacco suit. .%lrcv,ic-frr/ h7r Awcintic~r7 ]OllJ'JJO/ 1995;81 (Mav):22-3. Curriden M, Rodrigue G. State's tobacco suit aids criminal probe. Federal inquirv focuses on roles plaved by industry la\\, firms. Dnl/il> Mo,~rrir7;< ,"\jwts, O;t 6, 1997;Sect A:l. Davidson L, Slade J, Stang CL. Knolvledge and atti- tudes about tobacco among pharmacists who do and \vho do not sell tobacco. In: Aoki .M, Hisamichi S, Tominaga S, editors. SnJoX-ir~~y i7/Jd H~v7/t/J 7 98;: /`ro~-c~`~f- ill;;5 Of th i;f/J i'%;oJ'/d ~O,J~cWJJiC O/J SlJJdilJ;< i7JJd tfrYl/f/l, E?kyo, 9-12 No~vJJJ~~I. 191;. Amsterdam: Excerpta Medica. 1988:343-5. Da\,is A. Guatemala sues tobacco firms to reco\`er health-care costs. WnII Stwc? ]017rr7n/, May 13, 1998;Sect &13. Davis A, Duffy B. Double trouble? Criminal probes dogging industry. Wnll Sfrwf ]OllJ'JJn/, July 10, 1998;Sect B:l. Davis RM, Healy I', Hawk SA. Information on tar and nicotine yields on cigarette packages. A/TJU~COH ]orir- 11171 Of~d& HfVlf/J 1990;80(5):551-3. Daynard RA. Tobacco liability litigation as a cancer COlltrOl strategy. ]@111.1217/ of f/J? Nflfior~n/ Car~ccr IlJstifllfc 1988;80(1):9-13. Daynard RA. Filter tips: more ways to smoke the to- bacco companies; litigation. 1/Vns/JilJgfwl MoJ~thly 1993a; 25(1-2):lS. Daynard RA. Smoking out the enemy: new develop- ments in tobacco litigation. E.io1 1993b;29:16-23. Daynard RA. Catastrophe theory and tobacco litiga- tion. fijbacco COIJ~YOI 1994a;3(1):39-64. Daynard RA. The third \vave of tobacco products liability cases. Trinl 1994b;30:34-40. Daynard RA. Litigation by states against the tobacco industry. Tobacco 01 Trial 1997;3(Aug):3. Daynard RA, Morin L. The Cipollone documents: fol- loning the paper trail to tobacco industry liability. Trial 1988;24:50-4. Department of National Health and Welfare. Tobacco products control regulation. Car~orla Gaxrttc, Port II 1989;123(2):64. Department of National Health and Welfare. Tobacco products control regulations, amendment. Cnr~dn Cn- zc+tc', P177.t II 1 YY3;127(16):3277-84. Dieter M. Impact of Wiley case on other suits argued; tobacco industrv sees other M-ins, but foes disagree. Lo~~i~~~//l~~ Co~rl.ir,;,-/o~ir,rln/, Mar 21, 199X;Sect A:l. DiFranza JR. Sonar regulations. ~~lwcco At-cuss Laz jvw;, No\. lY93;21:1. DiFranza JR. Sabotaging enforcement efforts. %!JMCO Ai(~c'.i~ Lo:l' ~"V'LUV, May 1994a;24:1-8. DiFranza JR. Synar update. Tobncrc~ AcTL'~~ LOW NCWS, Ott 1994b;26:1-8. DiFranra JR. The empire strikes back. ToEncro Access Lw Ntws, July 1994c;25:1-8. DiFranza JR, Carlson RF', Caisse RE Jr. Reducing youth access to tobacco [letter]. TO~~CCU Coufrol 1992;1(1):58. DiFranza JR, Celebucki CC, Seo HG. A model for the efficient and effective enforcement of tobacco sales laws. hWk7lJ ]0111.1Jd Of PJib/iC HrV/flJ 1998;88(7):1100-1. DiFranza J, Godshall B. Tobacco industry lobbies to sabotage Synar law. Tdmcco-FYW Youtlr Rcporfcr 1994; 6(3):7-10. DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden in- fant death syndrome. ]oJivfrrr/ of fn/?Jil PmtiCe 19%; 40(4):385-94. DiFranza J, Librett J. State and federal revenues from tobacco consumed bv minors. /iJiJf'J'iCnJf /OJ,J'JJf7/ off uh- lif tlclnltl7 I YYY;89(7):i 106-P. DiFranza JR, Nor\\-ood BD, Garner DW, Tye JB. Leg-is- lati\re efforts to protect children from tobacco. \(lrirrrill c$ f/w .-2mrk~7~1 Mrdic~l .4ssorinfio/l 1987;257(23):3387-9. DiFranza JR, Richards JW, Paulman PM, Wolf-Gillespie N, Fletcher C, Jaffe RD, Murray D. RJR Nabisco's car- toon camel promotes Camel cigarettes to children. \0~1r- Jfd ,lf fh illll~').;ifl11 h4t'diifl/ ,`hCJiil7tiOJl 1991;266(22): 3149-53. DiFranza JR, Savageau JA, Aisquith BR. Youth access to tobacco: the effects of age, gender, vending machine locks, and "lt's the La\%-" programs. AIIwiC1711 ]olrr.,Inl c,fP~rtdic Htvltl~ 1996;86(2):221-4. Djordjevic MV, Hoffmann D, Glynn T, Connolly GN. US commercial brands of moist snuff, 1994. I. Assess- ment of nicotine, moisture, and pH. fi~hcco Cor!ttd 1995;4(1):62-6. Douglas CE. Criminal action against the tobacco in- dustry: serving the public health. In: Ahtr27rt5, 126th Annual Meeting and Exposition; NOI, 15-18, 199X; Washington, DC. Washington: American Public Health Association, 1998:l. Drug Abuse Ad\isorv Committee. Abuse liabilitv as- sessment of nicotine nasal sprat. Transcription of meet- ing no. 27 of the US Food anj Drug Administration, Center for Drug E\.aluation and Research, Drug Abuse Advisory Committee; Aug 1, 1991; Sil\,er Spring (MD). Duffy B, Taylor J. Liggett's cooperation kvith invcsti- gators changes politics of tobacco legislation. !N1711 Slm? ~orrrrrd, Mav 1, 1998;Sect A:16. Durkin T, Felstiner WLF. Bad arithmetic: disaster liti- Lyation as less than the sum of its parts. In: Jasanoff S, h editor. L1~7r1ri~7~q fmrrr Dk~~h~~: Risk M[rrrn~~cv/rL~fr~ ofto. R/w~wI. Philadelphia: University of Pennsylvania Press, 1991:158-79. Dillorlii/I il. Po!cJ/, Y3 Ohio App. 36 383, 638 N.E.Zd 636 (Ohio Ct. App. lYY4). Dybing E, Sanner T. Passive smoking, sudden infant death syndrome (SIDS) and childhood infections. Hrf- m7fr Esprrirmvrflr/ EJricrdr~~~y 1999;18(4):202-5. tcorwrlrist. The tobacco wars: looking for a landmark. Eco~m~i~t, July 11, 199X;Business Sect:&. Edell MZ. Risk utility analysis of unavoidably unsafe products. S&w Hlrll Lnw Rwim~ 1987;17:623-55. Edillnrrls ~1. GMXI, Ijlr., No. 119S93 (Md., Montgomery Cty. Nov. 26, 1997), cited i\r 13.1 TPLR 3.1 (1998). Eiwr!/ il. Cnrniwr~ of Dueaw, 11zr., 879 F. Supp. 640 (N.D. Tex. 1995). Emmons KM, Abrams DB, Marshall RJ, Etzel RA, Novotnl TE, Marcus BH, Kane ME. Exposure to envi- ronmental tobacco smoke in naturalistic settings. A~r~crl'car~ ]o~rnml of Prrtdic Hmlfh 1992;82(1):24-8. Emont SL, Choi WS, Novotny TE, Giovino GA. Clean indoor air legislation, taxation, and smoking behaviour in the United States: an ecological analysis. `iXwc to indi\.iduals under 18 vears of age (45 CFR Part %), 3 F-cd RL~s. 451 56 (lYY3j. ~`~~I~c~Q/ R~`~zqi~t~r. US Department of Labor, Occupational Safetv and Health Administration. lndoor air qualit\- `29 CFR Parts 1910, 1915, 1926, and 192X). 59 FnI RL~,<. I5968 (1994). Fc,lfcra/ Rc~~istw. US Department of Health and Human Ser\,ices, Food and Drug Administration. Analysis re- LTarding the Food and Drug Administration's jurisdic- &n over nicotine-containing cigarettes and smokeless tobacco products, 60 Frail. Rq. 41433 (1995a). ~c~L~c~~/ Rt;yisfn,. US Department of Health and Human Services, Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents (21 CFR Parts 801,803,804, and 897),60 f`p(I. Rq. 11311 ( 1995b). ~(x[/~lr~l Rqistrr. US Department of Health and Human Services, Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents (21 CFR Parts 801, 803, 801, 807, 820, and X97). 61 Fta,1 J+`y. 41396 (lYY6). F&P~~~/ R~~gi~tc~r~. L:S Department of Health and Human Ser\,ices. Notice regarding requirement for annual sub- mission of the quantity of nicotine contained in smoke- less tobacco products manufactured, imported, or packaged in the United States, 64 Fed. Rq. 14085 (1999). Federal Trade Commission. kpv'f to COI~~I~L'SS: f'urs~i- n,7t to r/~t~ Fcdml Cigawttc Lnbchg ilrrd Ahcrtisir7g Act. Washington: Federal Trade Commission, 1967. Federal Trade Commission. Rcprf fo Cortgwss: Plluszr- orrf to ti7c Fcdrwl C;p7rcftr, Lnbdir~g ar7d Adwfisir7~ Act ti)r tl7c 1inr 1987. Washington: Federal Trade Commis- sion, 1984. Federal Trade Commission. RqmY to Co77~~wss for 7 99.3: P7ir~;lll7lrt fc1 f/7(, Fdml Cigilwttc LdJdiJ7~ 171711 AlfWfi!+ irl;; .-2(-t Washington: Federal Trade Commission, 1995. Fcighcrb, E, Altman DG, Shaffer G. The effects of com- bining education and enforcement to reduce tobacco sales to minors: a studv of four northern California communities. ]07,r770/ of tl7c Ar~wicnr7 Mcdicol Associn- ticlr7 lYY1;266(22):3168-71. Ferris RI'. The role of smoking behaviour in product de\-elopment: some observations on the psychologi- cal aspects of smoking behaviour. Paper presented at the Smoking Behaviour-Marketing Conference; July 9-12, 1984; Montreal. X-58 Cn;~7s/xmwgl7 Stwef Realty Tnrsf 7'. Rem nt7d Kristy Hnillx, No. 98-02279, Boston Housing Court (1998). Fischer S, Castonguay A, Kaiserman M, Spiegelhalder B, Preussmann R. Tobacco-specific nitrosamines in Canadian cigarettes. ]wr~2fi/ ofG?rlrrr Rwnvrh m7d Cli77i- ii7l @l?`Ol"<~.`l 1990;116(6):563-8. Fischer PM, Schwartz MI', Richards JW Jr, Goldstein AO, Rojas TH. Brand logo recognition by children aged 3 to 6 years: Mickey Mouse and Old Joe the Camel. jorrrr7(7l of tlw .4,ncrii-n/7 Mcdicnl Associatiorr 1991 a; 266(22):3135-8. Fishman JA, Allison H, KnoM.les SB, Fishburn BA, Woollerv TA, Mars WT, Shelton DM, Husten CG, Eriksen -Mr. State lalvs on tobacco control--United States, 1998. Morbidif!/ 011~1 Mort~~lif!/ h'wkl!l RC/JOV~ 1999;48(SS-3):21-62. Floridn 71. hwi~-~~~~ Tolv7c~ Co., No. 951466AO (Fla., Palm Beach Ctv. Feb. 21, 19951, iitcii irz 10.1 TI'LR 3.1 (1995) (Complaint). Floridly ~1. .4r~1uicn~~ 7i~hico Co., No. CL 95-1466 AH (Fla., Palm Beach Cty. Sept. 16, 1996) (Order Granting, in Part, Defendants' Motions to Dismiss). Florid17 T. A~~wricflrl fi~b~lcrn Co., No. CL95-1166 AH (Fla., Palm Beach Ctv. Oct. 18, 1996), i-it~rl irk 11.7 TPLII 2.236 (1996) (Order Denying Defendants' Motion to Strike Plaintiffs' "List of Medicaid Recipients"). Flor-i& 7'. AIII~~~~T~~~~ Tolwizcl Co., Civil Action No. 95-1466 AH (Fla., Palm Beach Cty. Aug. 25, 1997) (Settlement Agreement). Fontham ETH, Correa I', Reynolds I', Wu-Williams A, Buffler PA, Greenberg RS, Chen VW, Alterman T, Boq;d P, Austin DF, Liff J, Environmental tobacco smoke and lung cancer in nonsmoking Lvomen: a multicenter studv. ]ollml OF t/l? Allli'l.iil?ll Mcifici7l Ai.5ocil7tior7 lw-l:271(22):17;2-Y. Forster J, Wolfson M, Claxton A, Murray D. Perceived tobacco availability and minors' purchase success in fourteen Minnesota cities. Paper presented at the an- nual meeting of the Anzevica~ Plrblic H~nlth A~~nciatio~~; Ott 29-Nov 2,1995; San Diego (CA). Forster JL, Hourigan M, McGovern P. Availability of cigarettes to underage youth in three communities. Pwwtlfiw Mcdicirzc 1992a;21(3):320-8. Forster JL, Hourigan ME, Kelder S. Locking devices on cigarette vending machines: evaluation of a city ordinance. Av~euirnrz /o~rr~irl uf Public Health 1992b; 82(9):1217-9. Forster JL, Klepp K-l, Jeffery RW. Sources of cigarettes for tenth graders in two Minnesota cities. Hdth Eil~- cxtior/ R~w~rcI~ 1989;4(1):45-50. Forster JL, Komro KA, Wolfson M. Survey of city ordi- nances and local enforcement regarding commercial availability of tobacco to minors in Minnesota, United States. Tr&ncco Corlfuol 1996;5(1):46-51. Forster JL, Murray DM, Wolfson M, Blaine TM, Wagen- aar AC, Hennrikus DJ. The effects of community poli- cies to reduce youth access to tobacco. Awricr7rr ]or~rrral of Pliblic tJPi?/fll 1998;88(8):1193-8. Forster JL, Wolfson M, Murray DM, Wagenaar AC, Claston AJ. Perceived and measured availability of tobacco to youths in 14 Minnesota communities: the TPOP studv. AI~IL,~.;c~~J~ /w~r~al of Pwwt~fiiv Medicim~ 1997;13(3):i67-74. Fourkas T, editor. Tcb~vc(~ Corrlrc~l irr CnliJovrzin Citirs: A Gi~idc iw Aztio,z. Sacramento (CA): California Depart- ment of Health Services, 1992. Frankel A. Blowing smoke. TI7e Anwricat7 Laqt~r 1995; 17(6):68-77. Fraser G. Strength of warnings on tobacco use reduced by lobbying, group charges. Gl& arlrl Mnil (Toronto1 June 26, 1989;Sect A:1 (co1 1). Freedman A. Consolidated U.S. tobacco probe focuses on companies' statements. Wn/l Stwrt ]olrrr2nl, Sept 3, 1996;Sect B:8. Freedman AM. Juiced up: how a tobacco giant doc- tors snuff brands to boost their "kick." l&/I Sftwf \o~[Y- IM/, Ott 26, 1994;Sect A:1 (co1 6). Freedman A, Jensen E, Stevens A. Why ABC settled with the tobacco industry. Wnll Strwf /011r11fl/, Aug 24, 1995;Sect B:l (co1 3). Freedman A, Lambert W. Tobacco probe examines se- curities aspect. Will/ Sfk'flf /0lirlml, Julv 27, 1995;Sect B::. Freedman A, Stevens A. Philip Morris is putting TV journalism on trial in its suit against ABC. Wo11 Sfwf /mcrrlal, May 23, 1995;Sect A:1 (co1 6). FTC: WATCH. FTC closing its Camel cigarettes ini,es- tigation without action. FPC: L%%TCH 1994;414:2-3. Galanter M. Why the "haves" come out ahead: specu- lations on the limits of legal change. Llw & Sot-irfy RP ilicu 1974;9(1):95-160. Galanter M. Reading the landscape of disputes: \1-hat lve know and don't know (and think we know) about our allegedly contentious and litigious society. UCLA hcl Rtview 1983;31(4):4-71. Galanter M. Case congregations and their careers. Lnill h Society Rruiw 1990;24(2):371-95. Galanter M. News from nowhere: the debased debate 011 civil justice. DAISY Uniwrsify Lnw Rwiew 1993;71(1): 77-113. Galanter M. The transnational traffic in legal remedies. ln: Jasanoff S, editor. Ltwr~ri~~~ Frr)~~r Di.mfu: RiskMm- ;~,~~`nwnt After Blropnl. Philadelphia: Universitv of Penn- sylvania Press, 1994:133-57. Gallup Organization, Inc. for the American Lung As- sociation. Sllrwl/ of f/w Plrblic's Affifudes Toz4u77d Smok- ~/IS. Princeton (NJ): Gallup Organization, 1992. Gallup Organization, Inc. for the Coalition on Smok- ing OR Health. Tlrc Public-4 Affifdes TOmrd Cipreffc Adwrfisir~cq 011[f Ciprcttr Tnr Ir7cveasc. Princeton (NJ): Gallup Organization, 1993. Gangarosa RE, Vandal1 FJ, Willis BM. Suits by public hospitals to recol'er expenditures for the treatment of disease, injury and disability caused by tobacco and alcohol. F0rd1w111 Llrbn,l Ln:cl ]ourrm/ 1994;22:81-139. Garner DW. Cigarettes and welfare reform. Emory La7u? ~~1.11a1 1977;26:269-335. Gemson D, Moats HL, Watkins BX, Ganz ML, Robin- son S, Healton E. Laying down the law: reducing ille- gal tobacco sales to minors in central Harlem. Amrrical~ /olrrjlul of Pl(blir Hcwlfll 1998;88(6):936-9. Gerlach KK, Shopland DR, Hartman AM, Gibson JT, I'echacek TF. Workplace smoking policies in the United States: results from a national survey of more than 100,000 workers. ~~l~ncr-o Corlfrol 1997;6(3):199-206. Gersten R. St. Peter gets tough on cigarette sales to vouths. Marrkoto Frw Pwss, Dee 13, 1994:15 (co1 1). Geyelin M. Tobacco companies are set back by actions in Florida, Mississippi. Wnll Strerf jourrm1, Feb 22, 1995; Sect B:l (co1 4). Geyelin "VI. Former researcher at Philip Morris sought immunity. WoII Sfrrcf jolrrru-rl, May 16, 1997;Sect B:13. Geyelin M. Release of tobacco documents ordered. Wall Sfrwf ]olrrrmI, Mar 9, 1998;Sect A:3. Giovino GA, Schooley MW, Zhu B-P, Chrismon JH, Tomar SL, Peddicord JP, Merritt RK, Husten CG, Eriksen MI'. Surveillance for selected tobacco-use behaviors-United States, 1900-1994. Modidity ad Marfolif{/ WLYJ~~JI RP/JCJI? 1994;43(SS-3): 1-43. Gallup Canada, Inc. for the Canadian Cancer Society. Fhl Rrporf 077 a Szuiy/ of Ci777ndil7rrs' K77oi4Mp~ ofn/7d ,-\ififudrs Toiclnrd fllc Hn;w7$4/ Effccfr of.S~~roki~~~y. Toronto: Gallup Canada, 1988. " Giovino GA, Tomar SL, Reclcl~~ MN, I'cddicord Jr', Zhu B-P, Escobedo LG, Eriksen Mb. Attitudes, knowledge, and beliefs about lot\.-vield cigarettes among adoles- cents and adults. In: T/w FTC Cj:+~wt~( Test Mctld for Dfwri7irrirr~ Tnr, .Nicotil7f~, (7/7d Crllh~ll Mf~77f~.YidL Y&s of U.S. ci$nreftc~. RqJorf of t/w i"v'cf ~`.YJJc',? Cmlluiiftw. Smoking and Tobacco Control Monograph No. 7. Bethesda (MD): US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, lY96:39-57. NIH Publication No. 964028. Gitlin R. Minnesota bans spur cigarette machine Icars. A~rcn'cnr~ Aufmnfic Mcrc-hrrtfiwr. 1991;33(10):12-6. Glantz SA, Smith LR. The effect of ordinances requir- ing smoke-free restaurants on restaurant sales. .4777f~r+ if711 ~Olim7l of PlfbliC HL'i7ltl7 lYYd;P4(i):1081-5. Glantz SA, Smith LRA. The effect of ordinances requir- ing smoke-free restaurants and bars on rc\`enues: a follow-up. ilwl.ic~~i~ ]w).1lfl/ c$ Pill~lic Hco/fh lc)Y;;87( 10): 1687-93. Goldstein AO, Fischer I'M, Richards JW Jr, Crcten D. Relationship betlveen high school student smoking and recognition of cigarette ad~~ertisements. /oilr-r777l Of Pedifltlics 1987;11O(3):388-Y 1. Goldstein AO, Westbrook WR, Ho~vell RE, Fischer PM. Hospital efforts in smoking control: remaining barri- ers and challenges. /f1111.1717/ ofFf7mily Pn7t-fit-c 1YcC;31(6): 729-31. Gori GB. Consumer perception of cigarette yields: is the message relevant? f&`Sr//i7lfJr-u fix!c(l/qq/ f777d f/717,-- 1ililcoIl~rk TilJl~`5, July 26, 1995;Sect A:l. Hilts I', Collins G. Documents disclose Philip Morris studied nicotine's effect on the body. New York Tinws, June 8, 1995;Sect A:l. Hinds MW. Impact of a local ordinance banning to- bacco sales to minors. Plrblic Hcnltl7 Reports 1992;107(3): 355-x. Hafer I, Nil R, Battig K. Nicotine yield as determinant of smoke exposure indicators and puffing behavior. P/laJ,rJn7ccJlogl/, Bi~c-h~,~fisf~~/ nr~d Bchnuinr 1991;40(1): 139-49. Hohler 8. Alleging tobacco conspiracy, Meehan to urge US grand jury inquiry. Bosforl Globr, Dee 14, 1994;3. Hohler B. Clinton offers own plan on tobacco. Bostorz Globr Sept 18, 1997:Sect A:3. Holding Ii. Taking a break-outdoors lawsuit challenges S.F. smoking ban. Snr~ Fw~cisro Cl~rwziclc, Feb 2,1994;Sect A:15. Hollie PG. Segmented cigarette market. New Yo& TiJJWS, Mar 23, 1985;Business Day Sect:29 (co1 3). Ho~lo~~v~~ ~1. Bristol-Mycrs Cur/j., 485 E2d 986 (D.C. Cir. 1973). Hotqcr P. Stnttlq Ttrlcltirl Aswci~trs. lttc., No. 95 C 4439, 1995 WL 683614 (N.D. 111. Nov. 17,199s). Homyer i'. Sfanlty TnIiIzit~ Assorii7f~`s, fnr., 91 F.3d 959 (7th Cir. 1996). Hoppock KC, Houston TP. Availability of tobacco products to minors. /(wr-~al ofF~~lil!/ Pracfrct~ lY90;30(2): 174-6. HormGtz P. Lori1lot.d Tolwcco Co., No. 965-245 (Super. Ct. San Francisco Cty. 1995), ii>/`t. ~lc,l&f, 118 S. Ct. 1797 (1998). Howard DJ, Ota RB, Brigs LA, Hampton M, Pritsos CA. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including in- creased production of 8-hydrosy-2'-deoxyguanosine. Cfitlcer Epidtwiolq~~, Biottmrkcrs b Ptwvtztiott 1998; 7(2):141-6. Howatt G. New challenges in tobacco case; ,Medica, HealthPartners sue to recover health costs. Mirrr~r~/lo- /is Sfar Tribu/w, Mar 12, 1998;Sect 1:,4. Hudzinski LG, Frohlich ED. One->,ear longitudinal study of a no-smoking policy in a medical institution. Clwst 1990;97(5):1198-202. H\vang SL. Florida legislature moves to cripple tobacco lawsuit. fi'nll Sfrwf ]01ir17nl, h4ay 9, 1995a;Sect B:6 (co1 5). Hwang SL. Library search hints of electrifying ne\vs from big tobacco. Wrll Sftwl /o~~rrrlrl, Feb 6, 1993b;Sect A:1 (co1 4). Hrvang SL. Tobacco memos detail passive-smoke attack. Inin Str'srf ]ouuto/, Apr 28, 1998;Sect B:l. Hwang SL, Ono Y. Companies crush out ties to ciga- rettes. Wnll Sfwct /~~1[~1~~1, Apr 3, 1995;Sect B:l (co1 4). IMPACT Research. Cli~~\rl Sfurl!/, Pnsk Brotrrl, Fiw- Cipwffe Pock: Results. Quebec (Canada): IMPACT Research, 1993. File 13-4092H. ~~npcria~ fic,bacco hnitcd u. COlll/liPt'~~ia~ urrkv7 Assurancp CO. of Corrrrdil, No. 500-05-014084-964 (Canada S. Ct., Prow of Quebec, Dist. of Montreal Jan. 12, 19961, cifrlj in 11.1 TPLR 3.39 (1996). I~J rc Atrhttcho~, 913 P.2d 221 (Kan. Ct. App. Mar. 22, 1996). 111 w Cjgnrettc Cases (Fla., Duval Cty. Jan. 23,1996), citecf irl 11.1 TPLR 2.3 (1996). ltz re Cow William Tobacco Co. (Miss. S. Ct.), cited irt 12.1 TPLR 2.1 (1997). ItI re Kirk Fordice as Gomwm ofMississippi (Miss. S. Ct.), ritrlf ill 12.1 TPLR 2.5 (1997). 112 re Philip Morris kc., 706 So. 2d 665, 1998 La. App. LEXIS 138 (4th Cir. Jan. 28,1998). Itt rc Pitnkertort Tuhacco CO., 115 F.T.C. 60, 1992 F.T.C. LEXIS 35 (F.T.C. Jan. 9,1992). ItI VP X.1. Reyttolds E)hacco Co., Docket No, 9285 (F.T.C., May 28, 19971, citcii it1 12.3 TPLR 8.1 (1997). ltt rc Uttiott Carbide Corp. Gns Plarrf Disaslrr nf Bhopal, Itdia ~IJ Decert~brr, 7984,634 F. Supp. 842 (S.D.N.Y. 19861, uff'd i/l purl 809 F.2d 195 (2nd Cir. 1987), cert. dertk!, 184 U.S. 871, 108 S. Ct. 199 (1987). 111 w Wilh- ~7. Wilk, 781 S.W.2d 217 (MO. App. 1989). Jacobson I'D, Wasserman J, Raube K. 7%~ Political Em- 1l~fiott of Ajlfi-snwkitzg Lqi~[~fiotl. Santa Monica (CA): RAND Corporation, 1992. Janofsky M. Big tobacco watching a small-claims court. Nczc, l'ork Times, June 21, 1993;Sect D:3 (co1 1). Janofsky M. Ailing smokers sue the tobacco industry h'w x~c,rk Ti!lws, May 7, 1994a;Sect 1 :ll (co1 1). Janofsky M. Mississippi seeks damages from tobacco companies. New York Tillws, Mav 24, 1994b;Sect A:12 (co1 5). Janofsky M. Philip Morris accuses ABC of libel. New York Titttes, Mar 25, 1994c;Sect A:15 (co1 1). Jar\.ik ME, Henningfield JE. Pharmacological adjuncts for the treatment of tobacco dependence. In: Orleans CT, Slade J, editors. Nit-otirw ,%ldirtin,l: Prirlc-if~I~~s niilj !2;~arri-rgf,rlrf~r~~. NervYork: Oxford Uni\,ersit); Press, 1993: 315-61. Jasanoff S. Remedies against hazardous exports: com- pensation, products liabilitv and criminal sanctions. In: Ives JH, editor. Trnrlsrmtio,m/ Cor;~rotio/rs nrld Ejwi- i.~~~lwvlf~l Colltlol I~SI~CS: T/w Es/wt of Hll:nnl. Boston: Routledge & Kegan Paul, 19X5:113-60. Jason LA, Ji I'Y, Anes MD, Birkheacl SH. Acti\.e en- forcement of cigarette control la\vs in the pre\.ention of cigarette sales to minors. ]our/7f7/ (IF t/k .Arfk~riiofr A,ldiii7l .q~%lCiilfi(lf? 1991;266(?2):315`)-61. Jrffcry RW, Kelder SH, Forster JL, French SA, Landn HA, Baxter JE. Restricti1.e smoking policies in the [yorkplace: effects on smoking pre\.alencc and ciga- rette consumption. PI.cTilcTrlfii,l' M~~~1ici1l~~ 19Y31;23( 1 ): 78-82. Jenks S. LoM-tar cigarettes pose hidden health threat, panel says. ]uur-rln/ of ti7v N17tio1717l Cfitiif,t. lrf5litifif~ I 995;87( 1): 15-h. Jinot J, Bayard S. Respiratory health effects of passi\.e smoking: EPA's weight-of-evidence analvsis. ]07~r~r7~7/ of c/;J7icic'l Epiffcfr7iull?